Caractérisation du rôle de LFA-1 dans l'infection des lymphocytes T CD4+ par le virus de l'immunodéficience humaine de type 1

Authors: Tardif, Mélanie
Advisor: Tremblay, Michel J.
Abstract: Since the first isolation of HIV in 1983, huge progress has been made in understanding the biology of the virus and the pathogenesis related to viral infection. HAART has truly revolutionized anti-HIV treatment and reduces AIDS-associated mortality and morbidity. However, the emergence of drug-resistant viruses has decreased the efficiency of HAART. Hence, development of more potent and less toxic drugs than those currently in use represents the next challenges. Recent insights into molecular events involved in viral attachment and entry processes have permitted creation of fusion inhibitors, a new class of anti-HIV drugs. Unfortunately, a number of recent studies revealed that HIV can develop resistance against these new inhibitors. Thus, the understanding of cellular factors collaborating in the early steps of HIV life cycle should be helpful in development of anti HIV drugs that might be less sensitive to viral mutations. The principal goal of this project was to investigate whether HIV-1-anchored host ICAM-1 participates in the initial steps of HIV 1 life cycle by its interaction with the integrin LFA-1 on target cells. Results confirm the determinant role of this cellular interaction during attachment and entry of viral particles into CD4+ T lymphocytes, a phenomenon linked to the activation status of LFA 1. Altogether, these data provide additional clues of the active role played by HIV-1-anchored ICAM-1 and host LFA-1 in the viral life cycle. Such information could be useful in the development of complementary drugs working in combination with fusion inhibitors.
Document Type: Thèse de doctorat
Issue Date: 2005
Open Access Date: 11 April 2018
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
22933.pdf6.4 MBAdobe PDFView/Open
All documents in CorpusUL are protected by Copyright Act of Canada.